Explore the latest in pneumonia, including advances in understanding the microbiology and optimal treatment of community-acquired and nosocomial infection.
This difference-in-differences analysis assesses whether an association exists between hospitals being acquired by private equity firms and hospital income, use, and quality in the United States.
This randomized clinical trial evaluates the effect of early tocilizumab administration vs standard therapy in preventing clinical worsening in patients hospitalized with COVID-19.
This randomized clinical trial examines the effects of tocilizumab vs usual care in patients hospitalized with COVID-19 and moderate-to-severe pneumonia.
This cross-sectional study assesses whether hospitals were incorrectly penalized or incorrectly nonpenalized by the Hospital Readmissions Reduction Program for patient readmissions for acute myocardial infarction, heart failure, and pneumonia.
This cohort study analyzes the association of Staphylococcus aureus colonization status with the occurrence of S aureus pneumonia among European patients in the intensive care unit.
This open-label randomized trial compares the effect of remdesivir (5 or 10 days) vs standard care on clinical status 11 days after treatment initiation among patients with confirmed SARS-CoV-2 infection hospitalized with moderate pneumonia (room air oxygen saturation >94%).
This cohort study examines the risk for aortic aneurysm or aortic dissection in patients receiving fluoroquinolones for treatment of pneumonia or urinary tract infection.
This cohort study evaluates whether the use of physical and occupational therapy in the acute care hospital is associated with 30-day hospital readmission risk or death.
This study uses Medicare data to estimate mortality differences for common medical conditions (pneumonia, heart failure, chronic obstructive pulmonary disease, urinary tract infection, others) at US critical access vs non–critical access hospitals between 2007 and 2017 with vs without adjustment for discharge diagnosis counts to assess the extent to which coding practices rather than illness severity might account for observed mortality differences.
This cohort study assesses the validity of organism-specific International Classification of Diseases, Ninth Revision (ICD-9) administrative codes for pneumonia in adult patients using microbiological data as the criterion standard.
This cohort study examines the prescribing rates and duration of antibiotic therapy in patients with possible pneumonia whose clinical signs are within the reference ranges.
This cohort study describes risk factors and clinical characteristics and outcomes in 201 patients with coronavirus disease 2019 (COVID-19) pneumonia who developed acute respiratory distress syndrome or died.
This cohort study examines the association of nonsteroidal anti-inflammatory drugs (NSAIDs) with adverse outcomes in patients hospitalized with influenza or influenza pneumonia.
This cluster randomized trial evaluates the effectiveness of Mouth Care Without a Battle, a program that increases staff knowledge and attitudes regarding oral hygiene, changes oral care, and improves oral hygiene, in reducing the incidence of pneumonia among nursing home residents.
This study uses a Delphi consensus process to identify information to be included in an advance informed consent form for an early-enrollment, noninferiority clinical trial of treatments for hospital-acquired and/or ventilator-associated bacterial pneumonia.
This study describes results of IgM and IgG antibody testing from throat swabs of newborns born to mothers with COVID-19 pneumonia.
This cross-sectional study evaluates whether hospital-specific adverse event rates are associated with hospital-specific risk-standardized 30-day episode-of-care Medicare expenditures for fee-for-service patients discharged with acute myocardial infarction, heart failure, or pneumonia.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: